Other Events ·
Medicus Pharma regains Nasdaq compliance with $1.00 minimum bid price requirement
MDCXMedicus Pharma Ltd.
Nasdaq notified Medicus Pharma Ltd. that it has regained compliance with the $1.00 minimum bid price requirement for continued listing, closing the matter as of October 23, 2026. This notice supersedes a delisting determination letter received on October 20, 2026, which had cited the company's failure to meet the requirement by the October 19 deadline and its ineligibility for an extension due to insufficient stockholders' equity. The company must continue to maintain compliance with Nasdaq's listing standards. Medicus Pharma Ltd. operates in the pharmaceutical industry.